PCN25 DRUG UTILIZATION AND COSTS FOR ERYTHROPOIESIS STIMULATING AGENTS (ESA) IN PATIENTS WITH BREAST, LUNG, OR GASTROINTESTINAL CANCER RECEIVING CHEMOTHERAPY
Abstract
Authors
MH Lafeuille RS McKenzie F Vekeman R Bailey CT Piech P Lefebvre